Orient EuroPharma Co., Ltd.
Research Orient EuroPharma Co., Ltd. (4120.TWO) on Bullrun: market cap TWD 3.98B, dividend yield 8.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4120.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyTWD
- Market capTWD 3.98B
- Dividend yield8.9%
- Financial periodQ2 2026
- RevenueTWD 1.19B
- Net income-TWD 183.01M
- Free cash flow-TWD 377.48M
- Gross margin47.0%
Valuation Snapshot
latest market cap is TWD 3.98B; dividend yield is 8.9%.
Peer valuation comparison
Latest dividend yield is 8.91% versus a Healthcare sector median of 2.4% (271.3% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 3.98B | n/a | 8.7% | 4 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 4 TWD, yield 8.9%.
About Orient EuroPharma Co., Ltd.
Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include weight management, andrology, cardiovascular, respiratory, neurology, cardiovascular, metabolism, obstetrics and gynecology, antibiotic, immunology, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk under the Karihome brand name;
ETFs that hold Orient EuroPharma Co., Ltd.
US-listed ETFs
Orient EuroPharma Co., Ltd. is held by 2 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:
| ETF | Weight | Fee |
|---|---|---|
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
Portfolios as filed with the SEC on Form N-PORT, dated July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Orient EuroPharma Co., Ltd.'s market cap?
Orient EuroPharma Co., Ltd.'s market capitalization is TWD 3.98B.
Does Orient EuroPharma Co., Ltd. pay a dividend?
Orient EuroPharma Co., Ltd. has a dividend yield of 8.9%.
What does Orient EuroPharma Co., Ltd. do?
Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include weight management, andrology, cardiovascular, respiratory, neurology, cardiovascular, metabolism, obstetrics and gynecology, antibiotic, immunology, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk under the Karihome brand name; and healthcare supplements for liquid nutrition, regular blood lipids, L-arginines, agile movements, and improved sleep qualities under the Nutrifuel brand name.